Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date
	Wellbeing and support-seeking in undergraduate medical students Proceeding/Conference:Association for Medical Education in Europe (AMEE) Virtual Conference	Chen, JYChin, WYTsang, JPYLau, WCS	2021
	Clinical outcomes associated with early in-hospital use of metformin, dipeptidylpeptidase-4 inhibitor or insulin in COVID-19 patients with type 2 diabetes: a territory-wide retrospective observational study Proceeding/Conference:Journal of Diabetes Investigation	Low, CHMKwok, ACYLui, YCALui, TWDLau, TKKAu, CHWong, CKH	2021
	Preadmission use of DPP4i reduced risks of hyperinflammatory syndrome, in-hospital death or invasive mechanical ventilation in COVID-19 patients with type 2 diabetes: a territory-wide retrospective cohort study Proceeding/Conference:Journal of Diabetes Investigation	Lui, YCAKwok, ACYLow, CHMLui, TWDLau, TKKAu, CHWong, CKH	2021
	Effect of hospital case volume on clinical outcomes of patients requiring extracorporeal membrane oxygenation: A territory-wide longitudinal observational study. Proceeding/Conference:40th International Symposium on Intensive Care & Emergency Medicine (ISICEM)	Yeung, PNPFang, SIp, SWALin, JCRNgai, CWSin, WCChan, WM	2021
	Characteristics and Outcomes of Patients with COVID-19 Admitted to Intensive Care Units – A Report from the Global COVID-19 Critical Care Consortium. Proceeding/Conference:Perfusion	Yeung, PNPDalton, HJWhite, NFraser, JF	2021
	Predictors of favourable neurological outcomes in a territory-first extracorporeal cardiopulmonary resuscitation programme Proceeding/Conference:Hong Kong Medical Journal	Li, ACCFang, SLin, JCRIp, SWAYeung, PNP	2021
	Clinical outcomes associated with early in-hospital use of metformin, dipeptidyl peptidase-4 inhibitor or insulin in COVID-19 patients with type 2 diabetes, a territory-wide retrospective observational study Proceeding/Conference:Stanford CARE Summer Research Symposium	Kwok, ACYLui, YCALow, CHMLui, TWDAu, CHChung, HSXiong, XWong, CKH	2021
	The cost-effectiveness of biologic/targeted synthetic/biosimilar disease modifying antirheumatic drugs: a systematic review. Proceeding/Conference:ISPOR Europe Conference 2021	Peng, KLi, XCheng, WTTong, XYeung, WYWHo, CTKLau, WCS	2021
	Long term nucleos(t)ide analogue therapy reduced the extent of HBV DNA integration in chronic hepatitis B patients Proceeding/Conference:Hepatology	Chow, NWong, DKHMak, LYFung, JYYSeto, WKWLai, CLYuen, RMF	2020
	Earlier and more frequent virological and clinical relapse after cessation of tenofovir disoproxil fumarate versus entecavir therapy: Results from a large, global, multi-ethnic cohort of chronic hepatitis B patients (RETRACT-B study) Proceeding/Conference:Journal of Hepatology	Choi, HSJHirode, GChen, CHSu, THWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, SSarowar, AChien, RNFeld, JForns, XSonneveld, MPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HKao, JHHsu, YCCornberg, MHansen, BJeng, RWJJanssen, H	2021
	Repeat dosing of the GalNAc-siRNA AB-729 in subjects with chronic hepatitis B results in robust and sustained HBsAg suppression Proceeding/Conference:Journal of Hepatology	Yuen, RMFBerliba, ESukeepaisarnjaroen, WStrasser, STangkijvanich, PHolmes, JLeerapun, AJucov, AThi, EPWattamwar, TSofia, MJSevinsky, HGray, KAntoniello, DEley, TPicchio, GSims, KGane, E	2021
	Preliminary on-treatment data from a phase 2 study evaluating VIR-2218 in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:Journal of Hepatology	Yuen, RMFLim, YSCloutier, DShen, LArizpe, APang, PTay, CThanawala, VGupta, SVCathcart, AGane, E	2021
	Effect of fine particulate matter (PM2.5) collected in Hong Kong on mitochondrial permeability transition pore in human airway epithelial cells Proceeding/Conference:Hong Kong Medical Journal	Liang, YChu, PHTian, LHo, KFIp, MSMMak, JCW	2021
	The impact of interferon beta-1b therapy on thyroid function and autoimmunity among COVID-19 survivors Proceeding/Conference:90th Annual Meeting of the American Thyroid Association (ATA)	Lui, TWDHung, FNILee, CHPLee, CHATam, ARPang, KPPHo, TYFong, HYLaw, CYTo, KKWLam, CWChow, WSWoo, YCLam, KSLTan, KCB	2021
	Incidence and factors associated with functional cure (HBsAg seroclearance) during ETV or TDF therapy for chronic hepatitis B (CHB): an international real-world study with long-term follow-up Proceeding/Conference:Hepatology	Hsu, YCYeh, MLWong, GLHChen, CHPeng, CYFerret, MABEnomoto, MXie, QTrinh, HNPreda, CLiu, LCheung, KSMHoang, JHuang, CFBarciela, MRKozuka, RIstratescu, DTsai, PCVargas-Accarino, ELee, DHHuang, JFDai, CYCheung, RChuang, WLYuen, RMFWong, VYu, M-LNguyen, MH	2020
	Effect of cigarette smoke on airway inflammation, mucus hypersecretion and endoplasmic reticulum stress in a three-dimensional co-culture model of airway epithelium and smooth muscle Proceeding/Conference:Hong Kong Medical Journal	Chen, RIp, MSMMak, JCW	2021
	Inhibition of hepatitis B surface antigen in chronic hepatitis B subjects by RNA interference therapeutic AB-729 is accompanied by upregulation of HBV-specific T cell activation markers Proceeding/Conference:Journal of Hepatology	Paratala, BPark, J-JGanchua, SCGane, EYuen, RMFLee, ACHMoore, CLam, AMSevinsky, HSims, KAntoniello, DSofia, MJPicchio, GThi, EP	2021
	Hepatic decompensation and hepatocellular carcinoma after stopping nucleos (t)ide analogue therapy: Results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study) Proceeding/Conference:Journal of Hepatology	Hirode, GHansen, BChen, CHSu, THWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, XChoi, HSJChien, RNFeld, JForns, XSonneveld, MPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HKao, JHHsu, YCCornberg, MJeng, RWJJassen, H	2021
	No emergent core inhibitor resistance in patients with chronic hepatitis B virus infection treated with Vebicorvir in combination with a nucleos (t)ide reverse transcriptase inhibitor. (Poster presentation: PO-1286) Proceeding/Conference:Journal of Hepatology	Yuen, RMFLocarnini, SRevill, PYan, ROuyang, LCai, DDelaney, WKitrinos, KThompson, AZoulim, FSulkowski, M	2021
	Safety, tolerability and pharmacokinetics (pk) of single and multiple doses of alg-010133, an s-antigen transport inhibiting oligonucleotide polymer (stops) for the treatment of chronic hepatitis B Proceeding/Conference:Journal of Hepatology	Gane, EYuen, RMFYogaratnam, JLe, KVuong, JChristopher, WGohil, VSchwabe, CAgarwal, KJucov, ALiu, JWLin, T-IBlatt, LChanda, SMcClure, MFry, J	2021